# Long Term Outcomes in β Thalassemia Major

> **NCT02307786** · — · COMPLETED · sponsor: **Ann & Robert H Lurie Children's Hospital of Chicago** · enrollment: 176 (actual)

## Conditions studied

- Thalassemia Major

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02307786
- **Lead sponsor:** Ann & Robert H Lurie Children's Hospital of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-11-13
- **Final completion:** 2016-11-30
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307786, "Long Term Outcomes in β Thalassemia Major". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02307786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*